UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

20 Apr 2007

UCB Announces Positive Top-Line Phase III Results for Keppra® as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age

Read More
23 Mar 2007

UCB Provides Update on CIMZIA(TM) for Crohn's Disease and Rheumatoid Arthritis in the US

Read More
20 Mar 2007

Keppra® Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types

Read More
12 Mar 2007

New European Approval for Xyrem® Provides Significant Advance in the Treatment of Narcolepsy

Read More
8 Mar 2007

UCB has sold successfully its stake in Cytec Industries

Read More
28 Feb 2007

UCB Full-Year 2006 Financial Results

Read More

Stay up-to-date on the latest news and information from UCB